Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIB Grifols in Congenital Fibrinogen Deficiency
NCT04636268Phase 3Withdrawn
- Sponsor
- Grifols
- Start
- Dec 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of Fibrinogen human in congenital afibrinogenemia, congenital hypofibrinogenemia, sponsored by Grifols. Planned start Dec 2023; status: withdrawn.
02
Drugs
Fibrinogen human
03
Conditions
congenital afibrinogenemiacongenital hypofibrinogenemia
Beyond the preview
Go deeper on NCT04636268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04636268.